Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.
The government has exempted customs duty on critical petrochemical products till June 30 amid the West Asia crisis. Here are five NSE-listed companies whose margins could improve.
While West Asia dominates headlines, China is quietly pulling ahead in biologics manufacturing. We dig into filings to see which Indian pharma companies are best prepared and which are falling behind.
US tariffs squeeze Indian garment exporters, but new trade deals with EU and UK are opening doors for electronics manufacturers and medical device makers. We dig into the filings.
As crude oil surges on Iran-Hormuz tensions and the Sensex crashes 1,700 points, renewable energy and solar stocks with strong order books stand to gain from accelerated energy transition.
The government is considering invoking the Essential Commodities Act to regulate bulk drug prices. We dig into filings to find which API makers face margin pressure and which formulation companies could benefit from cheaper inputs.
The West Asia conflict is pushing crude oil higher. We dug into quarterly filings of IndiGo, HINDPETRO, BPCL, Asian Paints, and Oil India to see who gets hurt — and who quietly benefits.
A US Supreme Court ruling rolled back Trump's 50% tariffs on India to 15%. We dug into corporate filings to find which NSE-listed exporters have the most US revenue exposure — and the most to gain.
The India-US tariff reset has cut duties on Indian textiles to 18%. We dug into filings of Welspun Living, Trident, Indo Count and others to find who benefits most.
DCGI intensifies enforcement against unauthorized GLP-1 weight-loss drugs. Filing evidence shows these five companies are building legitimate semaglutide pipelines and delivery devices.
India is considering an 11-12% tariff on select steel imports for 3 years. We dug into quarterly filings of JSW Steel, Tata Steel, Jindal Steel, SAIL, and Jindal Stainless to find who benefits most.
Accenture guided Q3 revenue below estimates, but Infosys, HCL Tech, Tech Mahindra, Mphasis, and Hexaware filings show deal wins, margin expansion, and AI-driven growth that the market is overlooking.
The US Supreme Court struck down Trump's elevated tariffs, resetting duties on Indian goods to 15%. We dig into filings to find which NSE-listed exporters stand to benefit most.
The US Supreme Court ruling resetting tariffs to 15% gives Indian textile and pharma exporters a reprieve. We dig into filings to find who benefits most.
With Brent crude above $100 amid the Iran conflict, we dig into corporate filings to find which Indian companies face margin pressure from surging oil — and which upstream and energy names stand to gain.
The US has launched a Section 301 trade investigation targeting India. We dug into filings of pharma, auto component, and aluminium exporters to find who is most exposed.